comparemela.com
  1. Home
  2. Live Updates
  3. Kim Thacker - Breaking News

Latest Breaking News On - Kim thacker - Page 1 : comparemela.com

BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update

/PRNewswire/ BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today.

United statesStanford schoolJohn mullalyKim thackerNetta blondheim shragaChaim lebovitsAntal pearl lendnerJonathan katzRalph kernSidney spectorLisa guitermanJames berryDrug administration for nurownStanford school of medicineCalifornia pacific medical centerResearch development

BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update

/PRNewswire/ BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today.

United statesStanford schoolJohn mullalyKim thackerNetta blondheim shragaChaim lebovitsAntal pearl lendnerJonathan katzRalph kernSidney spectorLisa guitermanJames berryDrug administration for nurownStanford school of medicineCalifornia pacific medical centerResearch development

Brainstorm Cell Therapeutics Inc s (BCLI) CEO Chaim Lebovits on Q1 2022 Results - Earnings Call Transcript

Brainstorm Cell Therapeutics Inc. (NASDAQ:NASDAQ:BCLI) Q1 2022 Earnings Conference Call May 16, 2022 8:00 A.M.

United statesKim thackerMichelle lorenzNetta blondheim shragaChaim lebovitsTom galassiBilly dunnDaniel walkerAntal pearl lendnerDavid setbounRalph kernAaron gertlerDavid bautzStacy lindborgCompany participantsBrainstorm cell therapeutics inc

BrainStorm Cell Therapeutics Announces First Quarter 2022 Financial Results and Provides a Corporate Update

/PRNewswire/ BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today.

United statesJohn mullalySeanm healeyKim thackerAntal pearl lendnerNetta blondheim shragaChaim lebovitsJames berryBrainstorm cell therapeutics incCalifornia institute for regenerative medicineLifesci advisorsDrug development summitInternational societyDrug administrationResearch developmentResearch summit on

BrainStorm Announces Presentation of NurOwn® Exosome Preclinical Data at ISCT 2022 San Francisco Meeting

/PRNewswire/ BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced the.

United statesSan franciscoJohn mullalyKim thackerRalph kernChaim lebovitsCalifornia institute for regenerative medicineBrainstorm cell therapeutics incLifesci advisorsInternational societyDrug administrationInternational society for cellNational ms societyEuropean medicines agencyBrainstorm cell therapeuticsGene therapy

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.